What to know
- NOFO Number: PS22-2203
- Application Due Date: November 19, 2021
- Letter of Intent Due Date: October 4, 2021
- The purpose of this page is to support applicants for Notice of Funding Opportunity (NOFO) PS22-2203.
Funding overview
The purpose of this program is to implement comprehensive high-impact human immunodeficiency virus (HIV) prevention programs. It addresses health disparities among vulnerable peoples and their partners to reduce HIV transmission and HIV-associated morbidity and mortality. The two categories addressed (and their partners regardless of age, gender, and race/ethnicity) in NOFO PS22-2203 are:
- Category A: HIV prevention services for Young Men of Color Who Have Sex with Men (YMSM of color)
- Category B: HIV prevention services for Young Transgender Persons of Color (YTG persons of color)
NOTE: Throughout this funding opportunity announcement, "young" and "youth" are defined as individuals between the ages of 13–34 years.
This program aligns with the goals of the HIV National Strategic Plan, 2021–2025 (HIV Plan). It supports the goals of reducing all new HIV infections by 75% by 2025 and 90% by 2030.
These support cooperative agreement programs for community-based organizations (CBOs) to develop and implement high-impact HIV prevention programs. CBOs are uniquely positioned to complement and extend the reach of HIV prevention efforts implemented by state and local health departments. They optimize services across public, private, and other CBOs to achieve objectives of:
- Increased HIV diagnoses identification.
- Referral for pre-exposure prophylaxis (PrEP) and non-occupational post-exposure prophylaxis (nPEP) services.
- Earlier entry to HIV care.
- Increased consistency of care.
Applicants are required to develop and implement a comprehensive high-impact HIV prevention program for the priority population clients. These clients are at increased risk for acquiring HIV or living with HIV. The program should align with the goals and objectives of the HIV Plan. It should also complement the Ending the HIV Epidemic in the United States (EHE) initiative.
Along with the HIV Plan, proposed programs should be guided by the principles of inclusion of an HIV status neutral approach. This approach addresses social determinants of health and syndemics (multiple biological or social factors that interact with each other). This helps achieve health equity among the priority populations.
Proposed programs should include the implementation and delivery of strategies and activities that:
- Prevent new HIV diagnoses.
- Link clients to HIV prevention and care services.
- Refer/provide clients to essential support services that aid in reducing HIV-related disparities and health inequities.
The overarching goals of this NOFO include the following:
- Prevent new HIV infections.
- Improve HIV-related outcomes for people with HIV (PWH).
- Reduce HIV-related disparities and health inequities.
- Promote health equity and achieve integrated coordinated efforts to address the HIV epidemic.
These goals will be achieved by enhancing community-based organizations' capacity to:
- Increase HIV testing.
- Increase linkage/re-engagement in HIV medical care for PWH.
- Increase linkage to PrEP services for individuals at increased risk for acquiring HIV.
- Increase Partner Services (PS) referrals.
- Provide/Refer clients to prevention and essential support services regardless of HIV status.
- Increase program monitoring and accountability.
More detailed information can be found on PS22-2203 NOFO and PS22-2203 Logic Model.
Important dates
Due date for Letter of Intent (LOI): October 4, 2021
Due date for applications: November 19, 2021, 11:59 p.m. U.S. Eastern Standard Time
Access and submission
Accessing NOFO PS22-2203
To view the entire announcement and learn more about the CDC application process:
- Go to www.grants.gov
- Click on Search Grants
- Select Opportunity Status Archived
- Enter CDC-RFA-PS22-2203 in the Opportunity Number box
- Press Search
Submitting the application
Applicants are required to include all of the following documents (as PDFs) with their application package at www.grants.gov:
- Letter of Intent
- Table of Contents
- Project Abstract Summary
- Project Narrative (20-page limit)
- Background and Approach
- Applicant Evaluation and Performance Measurement Plan
- Work Plan, Budget Narrative, and Data Management Plan
- Other submission requirements
After applying
Phase I
All applications are reviewed initially for completeness by CDC Office of Grants Services staff. Incomplete applications and applications that do not meet the eligibility criteria do not advance to Phase II review.
Phase II
An objective review panel will evaluate complete, eligible applications in accordance with the criteria section of the NOFO. The applications will be objectively reviewed and scored by an independent review panel.
Phase III
After the objective review, the next step of the review process is conducted during a pre-decisional site visit (PDSV). The intent of the PDSV is to assess the applicant's capacity to implement the proposed program. This assesses the physical location, staffing, viable board of directors, access to the primary population, potential partnerships and collaborators, etc.
Applications are funded in order by score and rank determined by the objective review panel. The following factors also may affect the funding decision:
- Preference to ensure equitable balance in terms of prioritized racial or ethnic minority groups
- Preference for the balance of funded applicants. This is based on
- Burden of HIV within jurisdictions
- Disproportionately affected geographic areas, measured by CDC (geographical diversity)
- Burden of HIV within jurisdictions
Recipients
Organization Name | Category | City | State | Funding Amount |
---|---|---|---|---|
AltaMed Health Services | A | Los Angeles | CA | $400,000 |
APLA Health & Wellness | A | Los Angeles | CA | $400,000 |
Asian & Pacific Islander Wellness | B | San Francisco | CA | $400,000 |
Atlanta Harm Reduction Coalition | A | Altanta | GA | $400,000 |
Birmingham AIDS Outreach, Inc. | B | Birmingham | AL | $400,000 |
BOOMHealth! | A | Bronx | NY | $400,000 |
Care Resources Community Health | A | Miami | FL | $400,000 |
Children Hospital of Philadelphia | A | Philadelphia | PA | $400,000 |
Community Health Awareness Group | A | Detroit | MI | $400,000 |
Community Wellness Project | B | St. Louis | MO | $400,000 |
Damien Center, Inc | B | Indianapolis | IN | $400,000 |
Empowerment Resources Center for Young Women | A | Atlanta | GA | $400,000 |
Family Health Centers of San Diego | A | San Diego | CA | $400,000 |
Health Emergency Lifeline | A | Detroit | MI | $400,000 |
Hyacinth AIDS Foundation | A | New Brunswick | NJ | $400,000 |
Inova Health Care Service | A | Fairfax | VA | $400,000 |
Jacksonville Area Sexual Minority Youth Network (JASMYN) | A | Jacksonville | FL | $400,000 |
Knights & Orchids Society Inc | B | Selma | AL | $400,000 |
Legacy Community Health Services | A | Houston | TX | $400,000 |
LGBT Life Center | A | Norfolk | VA | $400,000 |
Long Island Crisis Center Inc | B | Bellmore | NY | $400,000 |
Long Island Gay and Lesbian | B | Astoria | NY | $400,000 |
Los Angeles LGBT Center | A | Los Angeles | CA | $400,000 |
Mazzoni Center | A | Philadelphia | PA | $400,000 |
Migrant Health Center | A | Mayaguez | PR | $400,000 |
Montrose Center | A | Houston | TX | $400,000 |
My Brother’s Keeper, Inc. | A | Jackson | MS | $400,000 |
NO/AIDS Task Force | A | New Orleans | LA | $400,000 |
North Jersey AIDS Alliance dba NJCRI | B | Newark | NJ | $400,000 |
Positive Impact Health Centers | A | Duluth | GA | $400,000 |
Pride Center of Maryland | A | Baltimore | MD | $400,000 |
Puerto Rican Cultural Center | B | Chicago | IL | $400,000 |
Rain Inc | A | Charlotte | NC | $400,000 |
Someone Cares, Inc of Atlanta | B | Atlanta | GA | $400,000 |
Special Services of Groups, Inc | A | Los Angeles | CA | $400,000 |
Wyckoff Heights Medical Center | A | Brooklyn | NY | $400,000 |
Capacity Building Assistance (CBA)
Capacity Building Assistance (CBA) is the provision to improve the delivery and effectiveness of HIV prevention services.
For more information, please visit Effective Interventions.
Common questions
Please view common question and answers (Q&As) under each respective heading/section for responses to submitted questions.
Application information
Q: Can we submit an application and also be listed as a subcontractor on another application?
A: Yes.
Q: Does the 20-page limit pertain to narrative only or does it include attachments as well?
A: The 20-page limit pertains to the narrative only.
Q: Is the workplan part of the 20-page limit?
A: Yes, the workplan is part of the 20 pages.
Q: Must we use 12-point font for footnotes and tables, or can we use 10-point font for footnotes and tables?
A: The project narrative is written in 12-point font, 1-inch margins, number all pages. A font less than 12-point may be used for footnotes and tables.
Q: Can a previous CDC Notice of Award (NOA) be submitted as evidence of previous of work with a priority population?
A: A progress report from a previous CDC award may be used as evidence of previous work with the priority population.
Q: Does the table of contents or abstract count towards the 20-page limit?
A: No.
Q: For the MOU/MOA required for referrals for prevention and essential support services, could both of those be internal? For example, an MOU for our internal housing program and an MOU for our mental health counseling program?
A: Yes, that is acceptable. Those referrals may be internal or external.
Q: If we already have MOUs, can we just use them?
A: As long as your MOUs fall within NOFO requirements, they should be acceptable. The MOUs must outline all required NOFO activities.
Q: If we have a PrEP provider and an HIV care provider in-house, do we need to have MOUs with them?
A: Yes, it is acceptable to have service agreements with internal PrEP or HIV care providers. These service agreements can be internal or external to your organization. You should secure a service agreement from the internal clinic or have one on hand for submission with the proposal.
Q: Can the medical provider also be the PrEP provider? If so, are two service agreement submissions required or would one service agreement detailing the two services be sufficient?
A: Yes, the HIV medical provider can also be the PrEP provider. It is still required that applicants provide separate service agreements even if they will use the same provider.
Q: Can a service agreement that was signed within the last year be used for submission?
A: Existing service agreements may be submitted with the application. Service agreements should be reviewed and updated annually.
Q: Is there guidance or templates for service agreements and MOUs/MOAs?
A: The bottom of this page has links for required attachments. There is not a template for MOAs/MOUs and service agreements. However, the NOFO indicates what information should be included in specific service agreements and the content to include for MOAs/MOUs.
Award information
Q: Is the average award amount per year of $350,000 more likely to be around that amount? Can applicants apply for more than this amount?
A: There is no ceiling for the funding amount an organization may request. The anticipated average award is $350,000. If funded, your budget and program deliverables and allocations may need to be revised. They are also subject to approval by CDC based on the award amount. Please ensure a budget that adequately supports the proposed PS22-2203 program.
Q: When will we know if we are awarded?
A: The anticipated award date is April 1, 2022.
Budget
Q: Are lab costs, copays, and deductibles fundable by this grant?
A: Some lab costs are allowable. For example, it may include the processing of HIV tests and integrated screening tests. PS22-2203 funds may not be used to cover copays and deductibles for clients.
Q: May grant funds be used to lease a "safe space" for prevention services?
A: Recipient organizations must designate a dedicated physical space that is located either within the organization or off-site within close-proximity. It must be a culturally, linguistically, and age-appropriate safe space. Recipients must address at least two social determinant barriers that prevent priority populations from receiving quality HIV prevention and care services. Funds may be used for leasing a space, if deemed appropriate and based on program needs.
Q: Can grant funds be used to purchase a mobile unit for testing or to perform updates to a current mobile testing unit?
A: The purchase of a mobile van/unit or leasing a mobile van/unit may be an allowable cost. It must be listed in the application and initial budget. Approval, once funded, may be dependent on several factors and associated documentation will be required.
Q: May funds be used to lease a safe space facility for Prevention services?
A: Yes, it must be outlined within the program narrative application and budget.
Q: Can we use funds for rapid HIV testing kits?
A: Yes, funds may be used to conduct rapid testing.
Q: Can funds be used to pay for PrEP and nPEP doctor's visits and or exam related to that?
A: No, funds cannot be used to pay for PrEP and nPEP doctor's visits or associated exams.
Q: Should the budget narrative be only for one year? Or should we include a brief summary for the subsequent four years?
A: The budget narrative should only address one year. It should align with the SF-424A.
Q: Would you like us to submit a detailed budget spreadsheet in addition to the budget narrative and the SF424A?
A: No, the budget narrative should include all the cost details and supporting information. Please refer to the CDC Budget Preparation Guidance.
Q: Are we required to submit forms SF-424 and SF-424A? The NOFO on p. 68 states that they are for an international NOFO. This is a domestic NOFO.
A: It is a requirement to submit SF-424 and SF-424A for this NOFO. SF-424 is the application for federal assistance and must be filled for all NOFOs. SF-424A is the budget information for non-construction programs and is mandatory.
Q: The NOFO states that a document called "Indirect Cost Rate" should be included in your application. If you are using a de minimis, is there something that we are required to attach to the application? Or, should we just indicate that within the budget narrative?
A: Applicants may use the de minimus rate of 10%. It must be stated in a memo from the organization. Applicants' fiscal/business officer should submit a document that they would like to use the de minimis rate.
Q: What is the difference between direct and indirect costs?
A: Direct costs are directly associated with carrying out the program. Indirect costs are charged across the board. Applicants may choose to not plan to negotiate an indirect cost rate agreement. In this case, they must submit a letter saying you choose to use the 10% de minimis for the entire project.
Q: Can we use grant funds to distribute masks and other personal protective equipment (PPE) to clients?
A: Funds should be used for HIV prevention services only. If masks were purchased for conducting HIV testing, they may be provided to clients without a mask for services.
Q: Please clarify 75% and 25% details. Is it for us to break down in our budget core activities versus foundational activities? Is there a document that lists this?
A: There should be one budget that follows the funding categories outlined, e.g., personnel, fringe, supplies, and equipment. There is language that 75% of resources should go towards core components. We ask that applicants do not have two budgets, but to explain the 75/25% split in the detailed budget narrative. Items need to be clearly outlined, such as HIV testing and social marketing resources. Provide details and itemize so that the reviewer can understand the budget.
Q: Is the purchase of rapid HIV and hepatitis C virus (HCV) tests or laboratory fees for STD tests allowed?
A: Yes, these are allowable costs. However, HCV and STD laboratory costs are only allowable up to 5% of the total budget. This is noted under Integrated Screenings.
Q: Will CDC allow 100% salary coverage for HIV testers?
A: If they are dedicated staff for the PS22-2203 program, 100% of their salary may be covered with funding from this award. This must be noted in the organizational chart and budget narrative.
Eligibility
Q: Who is eligible to apply for PS22-2203 funds?
A: Applicant organizations should demonstrate that the organization is rooted in the community specific to the funding category. Applicants should have a history of providing services. They should also intend to implement HIV prevention services in the areas indicated in the NOFO (see pgs. 29, 41–42). Applicants must contact state health departments and have Attachment C: Health Department Letter of Support completed by their health department representative. Please refer to the Eligibility Information section in the NOFO (pgs. 41–42).
Q: Are universities eligible?
A: Institutions of higher education are not eligible for funding.
Q: Are health departments eligible to apply?
A: Health departments are not eligible to apply.
Q: Our agency is non-profit under the auspices of a university. Are we eligible to apply?
A: The applicant organization must not have a government affiliation. They also must not be under the administrative and management authority of a college or university.
Evidence of service
Q: What sort of documentation do we need to show that we have served the proposed priority population for over 24 months?
A: Examples of documentation of services could include progress reports, funding reports or awards, agency summary reports on activities/persons reached, etc. Additional examples are included in the NOFO.
Q: Is there a template for the evidence of service requirement?
A: There is not a template for evidence of service. Examples of evidence of service include letters from a non-CDC funder. Another example includes a progress report from a funder showing that you served the priority population for them.
Letter of Intent
Q: My organization did not submit a Letter of Intent. Can we still apply for PS22-2203?
A: The Letter of Intent (LOI) is not required. The LOI is optional and not binding. The purpose of an LOI is to allow CDC program staff to estimate and plan for the review of submitted applications. As long as applicant organizations meets the listed eligibility requirements, you may still submit an application.
Q: My organization would like to change our priority population and service delivery area from what we submitted on our LOI—is that possible?
A: The priority population or service delivery area(s) may differ from what was submitted in the LOI.
Q: If the LOI deadline was missed, is the organization eligible?
A: Applicants may submit an application in the absence of submitting the LOI.
Program requirements
Q: Can we serve more than one priority population?
A: This NOFO asks applicants to select only one priority population for the specific category of funding being applied to. Priority populations for Category A are Young Men of Color Who Have Sex with Men (YMSM of color). The priority populations for Category B are Young Transgender Persons of Color (YTG persons of color). Applicants may serve other clients, but 75% of the total number of clients you serve must be from the selected priority population. Applicants may only apply for ONE category (Category A or Category B).
Q: Can you provide clarification on the evaluation and performance measurement plan (EPMP)? Does a draft need to be submitted with the proposal?
A: The EPMP is not required with the application. CDC will work with recipients in the first six months to develop an EPMP. However, applicants must include performance targets in the work plan submitted with the application.
Q: How can I find out if my organization needs to submit Attachment D: Letter of Intent from a Physician for State Regulations and HIV Testing Activities? Can any licensed medical professional oversee the applicant's HIV testing program? For example, a Physician Assistant or Nurse Practitioner where they are working within the scope of their state licensure?
A: The requirement to complete Attachment D is dependent on the applicant's state laws and guidelines. State/local health departments can provide guidance on this requirement. Additionally, state health department representatives can provide guidance on the required service provider allowable based on the state guidelines and regulations.
Q: For a Federally Qualified Health Center (FQHC) considering applying, how do you define "majority" when it comes to testing conducted in an outreach setting?
A: The majority of the HIV testing must be conducted in an outreach setting (75% or greater). Up to 25% of HIV testing efforts can be conducted as routine, opt-out HIV testing.
Q: If the applicant is a clinical/medical provider, do we instead write a letter stating that we provide HIV specialty medical care?
A: Internal medical care providers may be used. Applicants will generate an internal MOU/MOA documenting the agreement.
Q: How is service area defined and what are the service area requirements?
A: Applicants may provide services in at least one, up to a maximum of three, service areas throughout the applicant's jurisdiction. The service areas, within the jurisdiction, must be in proximity of the applicant organization's address. Applicants must also have a history of providing service in the area. A service area may be a small as a city or as large as a multi-county neighboring region. The service area should be within a reasonable area that would allow clients access to services offered by your organization.
Q: Must a navigator be funded under this NOFO? Could an existing program be referred to if a navigation program funded by another project exists? If the agency has a HIV Navigator employed with other funding, is it necessary to use PS22-2203 funds to do so?
A: Funded organizations must employ at least one trained HIV Navigator (a minimum of 0.5 FTE) within the agency to help. They must facilitate the coordination of the organization's linkage to HIV Medical Care plan activities. The navigator may work to service clients across the PS22-2203 program and the existing program in your organization.
Q: Are incentives allowable?
A: Incentives are allowable. Incentives must be appropriate for the priority population and are subject to approval by CDC based on the award amount.
Q: Can the priority population be MSM of any race or does it have to be MSM of a specific race/ethnicity?
A: For Category A, the priority population must be young MSM (YMSM) of color (i.e., racial/ethnic minority YMSM). At a minimum, 75% of clients served must be YMSM of color.
Q: We have an in-house data specialist. Do we need to put in funding for hiring an outside evaluator?
A: It is not necessary to hire an outside evaluator. CDC can assist with in-house evaluation. Applicants need to have someone for data entry at least half-time. If applicants feel the need specific evaluation that is not related to program specifically, you can hire an outside evaluator.
Q: Does the data management plan need to be included with this application? If it does, is it part of the narrative?
A: The data management plan can be included in the narrative. CDC will work with recipients in the first six months to develop an evaluation performance and measurement plan (EPMP). This includes the development of a data management plan. However, applicants must include performance targets in the work plan submitted with the application.
Q: If key personnel positions have not been filled yet (e.g., program manager), should we include a job description as a Resume CV attachment? Or should we just leave that position out of that section?
A: Please provide a job description in the budget narrative and mark it as To Be Determined (TBD).
Q: Is it possible to submit more than one MOU for a medical provider, PrEP provider, and prevention and essential support services?
A: At least one service agreement is needed with the application for an HIV medical provider. Additionally, at least one service agreement is needed for a PrEP services provider. Two MOAs/MOUs should be provided for prevention and essential support services. Once awarded, your PO will assist you with MOUs/MOAs for the essential support services needed by your priority population.
Q: Can we fund staff to do integrated screenings?
A: If applicants have the capacity or are already implementing integrated screening, up to 5% of requested funds can support these activities. Applicants must establish a service agreement with a clinical care provider to offer those services if they are not already offered.
Q: Can we use PS22-2203 funds to hire a social worker to deliver mental health counseling services?
A: Clinical services are not an allowable cost under this NOFO. Funds cannot be used for social work or mental health or substance use counselors.
Q: Can you clarify the requirement for a safe space? What is meant by safe space?
A: Applicants are required to identify a physical space for priority populations. It can serve as a primary point for recruitment and offering risk reduction skills and tools. It can also provide an opportunity to empower priority populations. CBOs are required to address at least two social determinants of health that impact HIV prevention outcomes with the priority population. It should be a culturally, linguistically, and age-appropriate environment. For example, if an assessment discovers housing is an issue, addressing it can make HIV prevention easier for priority populations.
Q: Can the safe space be an office, or should it be a common area?
A: The safe space can be within the applicant's office or in a nearby location. It must be easily accessible to the applicant's priority population.
Q: Is there a required format for the work plan? Should the logic model be used for a format?
A: The work plan should be included with the narrative. There is not a specific format. The logic model does not need to be used as a format for the work plan. However, applicants can use it to guide activities to be addressed in the work plan.
Q: Is CDC suggesting or requiring a grid or table format for the work plan?
A: There is no specific format for the work plan. However, the work plan must be included in the 20-page limit of the project narrative. Project narratives must be written using 12-point font, 1-inch margins, and all pages numbered. Applicants who wish to use a template may find a sample work plan template in the Attachments and important resources section at the bottom of this page.
Q: For the work plan, should the "outcomes" response be just the verbs (increase, decrease) or also the targets (objectives)?
A: The work plan should incorporate your SMART objectives for the specific project outcomes. It is not enough to only include increase/decrease for the outcomes. Work plans should encompass the strategies and activities to be conducted and the associated outcomes from those proposed strategies and activities. The logic model is a guide that can assist you with the development of your work plan inclusive of SMART objectives.
Q: If we choose Category A over Category B, can we still provide services to community members who fall under Category B?
A: Yes, but if Category A is chosen, ensure HIV testing activities include at least 75% of Category A priority population members. At least 75% of HIV tests must be from the proposed priority population.
Q: Are partners counted in the 75% of tests done with the priority population and not in the 25% of non-priority tests? If yes, how do we document that they are a partner of a member of the priority population?
A: Partners of the priority population would count in either the 75% or 25% populations depending upon their own risk and association. If they are a member of the priority population, their test would be counted in the 75% population. For example, if the priority population is AAMSM and the partner tested is AAMSM, then the partner is counted as priority population. If the partner is a white MSM, then they would be part of the 25% population.
Q: Is there a target number of patients applicants are expected to see?
A: Performance targets should be determined by the applicant's area, but there are requirements for number of new HIV diagnoses. For Category A, the number of new HIV diagnoses is eight, and for Category B, the number is six. Work with local and state health departments to help develop targets for other required NOFO activities. Historical program data is one data source you can use.
Risk reduction behavioral interventions
Q: Can you give us advice on how to budget for interventions?
A: On the CDC Effective Interventions website, there are links to all of the public health strategies and interventions. Some sections have information about budgets and cost analysis, as well as incentives that may be allocated. Costs must be reasonable and related to what you say you are going to do.
Q: Can we propose to implement the other CDC-approved evidence-based interventions or can we only use those listed in the NOFO?
A: The only allowed risk reduction behavioral interventions for implementation under PS22-2203 are the interventions listed in the PS22-2203 NOFO.
Q: Are Behavioral Health interventions required or optional?
A: All HIV High Impact Behavioral Interventions are optional.
Q: Are CDC intervention trainings free?
A: Yes, the intervention trainings are free.
Q: Does Safe in the City have to be implemented in a waiting room?
A: No, it can be offered in other parts of the agency. These free videos can provide more information.
Q: Are applicants allowed to use interventions that are found effective with their priority population but are not listed in the NOFO? There are several interventions on the CDC website, so do we have to offer only the ones listed in PS22-2203?
A: The interventions listed in the NOFO under Risk Reduction Behavioral Interventions are the only interventions allowed with PS22-2203 funds. Offering a behavioral intervention is not required under this program. If a behavioral intervention is not offered, please choose one that fits the priority population.
Submission
Q: Do we also need to submit the other CDC assurances (e.g. non-construction programs)?
A: Yes, CDC Assurances and Certifications are required with your submission.
Q: Can members of the board or staff members from different departments be designated panel members for the Assurance of Compliance form? Should we ask the health department for a representative as well, since there is a place on the form for one?
A: Members may be board members, program staff members, community members, community advisory board members, etc. Ensure that the members represent the applicant's community or priority population. Additionally, one health department representative (city, local, county, or state) should be included.
Q: Is there a template for the duplication of efforts report?
A: There is no template for the duplication of effort report. Submit a written statement of whether this application will overlap with another application or award in the same fiscal year. Applicants need to submit this as part of their application, even if they do not have duplication of effort.
Q: Can we attach more information at the end of the Linkage to Care form?
A: Yes, applicants may include current Linkage to Care protocols or policies in lieu of the form or develop their own form. Include any tables, diagrams, etc., that will not fit on the form, but the information must be included in the document.
Q: Our agency does not participate in lobbying activities. Do we still need to submit the form?
A: The lobbying activities form is still required. Please complete it with all related information and include N/A for the activities that do not apply to your agency.
Q: Can an organization submit two separate applications? For example, one for young men who have sex with men (YMSM) and one for young transgender (YTG) persons? Or can they only apply for one category?
A: Only one application will be accepted. Applicants must choose only one category.
General overview presentations
NOFO programmatic & evaluation overview
HIV testing interventions & strategies
- PS22-2203_HIV Testing & Interventions Strategies-Focused HIV Testing
- PS22-2203_HIV Testing & Interventions Strategies-Public Health Strategies & Interventions
Budget development & application submission process
Contacts
For programmatic technical assistance, contact:
Erica K. Dunbar, Senior Advisor
Division of HIV/AIDS Prevention
Centers for Disease Control and Prevention (CDC)
1600 Clifton Road NE-MS US8-3
Atlanta, GA 30329
Email: CBOFOA@cdc.gov
For financial, awards management, or budget assistance, contact:
Edna Green, Grants Management Officer, Grants Management Specialist
Department of Health and Human Services
Office of Grants Services (OGS)
2939 Flowers Road, M/S TV-2
Atlanta, GA 30341
Telephone: (770) 488-2858
Email: EGreen@cdc.gov
National HIV Prevention Monitoring and Evaluation
Please direct all questions regarding training modules and NHM&E requirements to the NHM&E Service Center.
NHM&E Service Center Main Line: 1-855-374-7310
NHMEservice@cdc.gov
Monday–Friday, 8:30 am to 5:00 pm (ET)
All CDC business days
For all EvaluationWeb® questions or technical assistance on entering/uploading data, contact the Luther Consulting Helpdesk at 1-866-517-6570 (option 1) or help@lutherconsulting.com.
Evaluation Web Resources
Click on the blue question mark (?) in the upper right corner to access resources
Evaluation and Performance Measurement Plan Template
E-Authentication Process
Email: Lourdes Gordillo at hkq7@cdc.gov
Attachments and important resources
- PS22-2203 Attachment A: Letter of Intent
- PS22-2203 Attachment B: Capacity & Proposed Priority Population Worksheet
- PS22-2203 Attachment C: HD Letter of Support
- PS22-2203 Attachment D: LOI from Physician
- PS22-2203 Attachment E: Linkage to HIV Medical Care PrEP Provider Plan
- PS22-2203 Attachment F: Social Media Program Guidance
- PS22-2203 Attachment G: Work Plan Guidance
- PS22-2203 Attachment H: Assurance of Compliance Content Review
- PS22-2203 Attachment I: Sample Table of Contents
Program Guidance and related links
National HIV Strategic Plan
Ending the HIV Epidemic in the United States
- Ending the HIV Epidemic in the United States – (https://www.hiv.gov/federal-response/ending-the-hiv-epidemic/overview)
- https://www.cdc.gov/endhiv/index.html
Effective Interventions & High Impact Prevention (HIP)
- Effective Interventions | HIV/AIDS | CDC
- High-Impact HIV Prevention: CDC's Approach to Reducing HIV Infections in the United States
Health Equity Guidance
- Health Equity Guiding Principles for Inclusive Communication | Gateway to Health Communication | CDC
HIV Testing
- Morbidity and Mortality Weekly Report: Recommendations and Reports September 22, 2006 / Vol. 55 / No. RR-14
- Implementing HIV Testing in Nonclinical Settings: A Guide for HIV Testing Providers
Partner Services
PrEP Guidance
- https://www.theaidsinstitute.org/index.php
- The U.S. Public Health Service's Clinical Practice Guideline, updated in 2021, provides the framework for clinical prevention with PrEP.
- Updated Guidelines for Antiretroviral Postexposure Prophylaxis After Sexual, Injection-Drug Use, or Other Nonoccupational Exposure to HIV—United States, 2016
Prevention w/Positives (PwP) Guidelines
Syringe Services Program (SSP)
Transgender Toolkit
Data Security and Confidentiality Guidance
Content Review Guidelines